Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

FDA Warns Invokana Can Lead to Ketoacidosis

 



(Medical-NewsWire.com, June 12, 2015 ) Las Vegas, NV -- Invokana (Canagliflozin) is manufactured by Johnson & Johnson and was approved by the FDA in 2013 to treat symptoms of diabetes.



Invokana has recently been linked to serious side effects including urinary tract infections, hypersensitivity, dehydration, and kidney damage. Another serious side effect of the drug is ketoacidosis.



To understand more about these side effects and why they occur, it’s best to understand how Invokana works. The medication adjusts the normal functionality of the kidneys for sugar to be excreted through the patient’s urine. This inhibition of the kidneys creates a high level of acid (known as ketones) in the blood. So much so, in fact, that it can lead to a serious disease known as ketoacidosis. Symptoms of ketoacidosis may include vomiting, pain, confusion, fatigue, and can lead to a coma or even death.



In March of 2015, the FDA released a warning about ketoacidosis from Invokana and other medications in the SGLT2 class. They advised that anyone suffering from the bad side effects of Invokana should immediately seek medical care. Hundreds of cases of serious injury have been reported by patients taking the drug.



If you have taken Invokana and endured an adverse reaction, we urge you to seek medical treatment. Secondly, please call the law office of Ed Bernstein & Associates to see if you have a case. Dial 888-235-3090 or visit https://www.edbernstein.com to get legal help now.





Ed Bernstein

.

888-235-3090

.

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC